Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Oncology|May 1, 2026
Bone-modifying therapy in multiple myeloma: a comprehensive reviewMartina Bogeljić Patekar, Vibor Milunović, Inga Mandac Smoljanović, et al.
Current Oncology Reports|April 12, 2023
First-Line Therapy for Nodal T-cell Non-Hodgkin Lymphomas: an Unmet Need in HematologyVibor Milunović, Inga Mandac Smoljanović, Martina Bogeljić Patekar, et al.
Acta Clinica Croatica|June 7, 2019
BENDAMUSTINE: AN OLD DRUG IN THE NEW ERA FOR PATIENTS WITH NON-HODGKIN LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIAMartina Bogeljić Patekar, Vibor Milunović, Karla Mišura Jakobac, et al.
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|November 7, 2012
[Extramedullary multiple myeloma of the colon--case presentation and literature review]Inga Mandac Rogulj, Bojana Aćamović, Tajana Filipec-Kanizaj, et al.
Cancers|February 10, 2024
Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins's Lymphoma Patients-A Single Centre ExperienceLea Galunic Bilic, Fedor Santek, Zdravko Mitrovic, et al.
La Radiologia Medica|March 15, 2023
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experienceLea Galunic Bilic, Fedor Santek, Josip J Grah, et al.
Lijecnicki Vjesnik|August 28, 2018
[GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROME]Njetočka Gredelj Šimec, Gordana Kaić, Anita Škrtić, et al.
Biomedicines|November 26, 2022
Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A ReviewVibor Milunović, Ida Hude, Goran Rinčić, et al.
Cancers|July 29, 2025
Efficacy, Toxicity and Effect of Pretreatment Cardiologic Consultation on Outcomes of Ibrutinib Therapy for Chronic Lymphocytic Leukemia-A KroHem StudyInga Mandac Smoljanović, Igor Aurer, Nikola Bulj, et al.
American Journal of Hematology|February 26, 2020
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study groupYair Herishanu, Adir Shaulov, Riva Fineman, et al.
Pageof 3